nc435

NC435 is a chemical compound with the molecular formula C17H21N3O2. It is a derivative of the benzodiazepine class of drugs, specifically a triazolobenzodiazepine. NC435 was developed by Neurocrine Biosciences and is used as a research tool in the study of benzodiazepine receptors and their role in various physiological and pathological processes.

The compound is known for its high affinity for the benzodiazepine receptor, particularly the alpha 1 subunit. This makes it useful in pharmacological research to study the effects of benzodiazepines on central nervous system function. NC435 has been used in in vitro and in vivo studies to investigate its potential therapeutic applications, including in the treatment of anxiety, depression, and other psychiatric disorders.

However, it is important to note that NC435 is not approved for human use and is primarily used in research settings. Its use is regulated by the Food and Drug Administration (FDA) and other regulatory bodies to ensure the safety and ethical use of research chemicals. The compound is typically administered in controlled environments to minimize potential risks to human health and the environment.

In summary, NC435 is a triazolobenzodiazepine derivative with high affinity for the benzodiazepine receptor. It is used as a research tool to study the effects of benzodiazepines on the central nervous system. While it has potential therapeutic applications, it is not approved for human use and is regulated by regulatory bodies to ensure its safe use in research settings.